Educational Grants - Medical Education Requests

Grants to USA nonprofit organizations and for-profit continuing medical education providers for education programs for healthcare providers in the areas of mental health and opioid dependence. Funding is intended for continuing medical education (CME) activities, including live, print, enduring, and/or web-based activities. Grant requests must be unsolicited, should typically have multiple funders, support education on a wide range of treatment options, not promote a particular medicine and must not provide nor promise to Alkermes any tangible benefit.
Alkermes is interested in collaborative submissions between CME providers partnering with professional organizations of practitioners who focus on the treatment of persons with schizophrenia, bipolar disorder, alcohol use disorder, or opioid use disorder. Examples might include proposals for CME activities for regional meetings of psychiatric or addiction practitioners, or partnering with advanced practice nurse, case manager, or pharmacist societies in their CME efforts for their constituents.Alkermes is currently accepting proposals that address the topic areas listed below.Alcohol Use DisorderIncreasing awareness and understanding of alcohol use disorder (AUD), medication treatment options and treatment guidelinesReducing barriers to treatment initiation for patients with AUDExploring factors that influence and improve retention in treatment for patients with AUDIntegrating medication for the treatment of AUD into outpatient practiceOpioid Use DisorderIncreasing awareness and understanding of opioid use disorder (OUD), medication treatment options and treatment guidelinesReducing barriers to initiation of treatment for patients with OUDExploring factors that influence and improve retention in treatment for patients with OUDImproving the awareness and understanding of long-acting injectable medications for the treatment of OUDImproving the understanding of comparative effectiveness data for the treatment of OUDSchizophreniaUnderstanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of schizophrenia:suboptimal therapeutic responsegaps in medication adherenceside effects associated with treatmentEmerging pharmacologic approaches and their mechanism of action for the treatment of schizophreniaUsing patient-centered approaches to optimize treatment of schizophreniaBipolar DisorderUnderstanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of bipolar disorder:suboptimal therapeutic responsegaps in medication adherenceside effects associated with treatmentEmerging pharmacologic approaches and their mechanisms of action for the treatment of bipolar disorderUsing patient-centered approaches to optimize treatment of bipolar disorder